PMID- 33486878
OWN - NLM
STAT- MEDLINE
DCOM- 20211215
LR  - 20211215
IS  - 1753-0407 (Electronic)
IS  - 1753-0407 (Linking)
VI  - 13
IP  - 8
DP  - 2021 Aug
TI  - Measuring the global, regional, and national burden of type 2 diabetes and the 
      attributable risk factors in all 194 countries.
PG  - 613-639
LID - 10.1111/1753-0407.13159 [doi]
AB  - BACKGROUND: No detailed quantitative global, regional, or national estimates of 
      the disability-adjusted life years (DALYs) of type 2 diabetes mellitus (T2DM) are 
      available. METHODS: We used data from the Global Burden of Diseases, Injuries, 
      and Risk Factors Study (GBD) 2017 to estimate the global, regional, and national 
      incidence rates and DALYs of T2DM, as well as the associated risk factors, in all 
      194 countries and territories by age, sex, and sociodemographic status during the 
      period from 2007 to 2017. RESULTS: Globally, the age-standardized incidence and 
      DALY rates increased by 3.23% and 5.07% during 2007 to 2017, respectively. The 
      age-standardized incidence and DALY rates in 2017 and the corresponding 
      percentage changes during 2007 to 2017 were highest in the low-middle 
      sociodemographic index (SDI) quintile. Regionally, the highest 2017 
      age-standardized incidence and DALY rates were observed in Oceania, whereas the 
      largest percentage increases in both rates during 2007 to 2017 were observed in 
      Southeast Asia. Nationally, Iran, the United Kingdom, and Indonesia reported the 
      largest percentage increases in the age-standardized incidence rates, whereas 
      Georgia, Czech Republic, and Iran showed the largest percentage increases in the 
      age-standardized DALY rates. Globally, the largest percentage increases in 
      risk-attributable DALYs were associated with a high body mass index, low physical 
      activity level, high fasting plasma glucose level, and high sugar-sweetened 
      beverage and red meat consumption. CONCLUSIONS: The global T2DM age-standardized 
      incidence and DALY rates increased globally between 2007 and 2017, especially in 
      the low-middle SDI quintile, Southeast Asia.
CI  - (c) 2021 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John 
      Wiley & Sons Australia, Ltd.
FAU - Yu, Mei
AU  - Yu M
AD  - Department of Endocrinology, People's Hospital of Yuyao, Ningbo, China.
FAU - Zhan, Xiaoqing
AU  - Zhan X
AUID- ORCID: 0000-0002-7476-8931
AD  - Department of Geriatrics and Traditional Chinese Medicine, People's Hospital of 
      Yuyao, Ningbo, China.
FAU - Yang, Zhenxing
AU  - Yang Z
AD  - Department of Endocrinology, People's Hospital of Yuyao, Ningbo, China.
FAU - Huang, Yongmin
AU  - Huang Y
AD  - Department of Endocrinology, People's Hospital of Yuyao, Ningbo, China.
LA  - eng
GR  - 2017YFC1310902/National Key R&D Program of China/
GR  - 2018YFC1315305/National Key R&D Program of China/
GR  - PPXK2018-02/Ningbo Health Branding Subject Fund/
GR  - SZSM201803080/Sanming Project of Medicine in Shen-zhen/
PT  - Journal Article
DEP - 20210212
PL  - Australia
TA  - J Diabetes
JT  - Journal of diabetes
JID - 101504326
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Cost of Illness
MH  - Diabetes Mellitus, Type 2/*epidemiology/etiology
MH  - Disability-Adjusted Life Years
MH  - Female
MH  - Global Health
MH  - Humans
MH  - Incidence
MH  - Male
MH  - Middle Aged
MH  - Risk Factors
MH  - Young Adult
OTO - NOTNLM
OT  - 2型糖尿病
OT  - disability-adjusted life years
OT  - global burden of disease
OT  - incidence
OT  - type 2 diabetes mellitus
OT  - 全球疾病负担
OT  - 发病率
OT  - 残疾调整生命年
EDAT- 2021/01/25 06:00
MHDA- 2021/12/16 06:00
CRDT- 2021/01/24 20:55
PHST- 2021/01/11 00:00 [revised]
PHST- 2020/11/16 00:00 [received]
PHST- 2021/01/20 00:00 [accepted]
PHST- 2021/01/25 06:00 [pubmed]
PHST- 2021/12/16 06:00 [medline]
PHST- 2021/01/24 20:55 [entrez]
AID - 10.1111/1753-0407.13159 [doi]
PST - ppublish
SO  - J Diabetes. 2021 Aug;13(8):613-639. doi: 10.1111/1753-0407.13159. Epub 2021 Feb 
      12.